Skin symptoms may clear with biologics in psoriasis, but hidden internal inflammation often persists, contributing to major ...

New research shows that in patients with psoriasis, even though their skin responds well to treatment with biologics, ...

Starjemza (ustekinumab-hmny) was approved by the FDA this week as a biosimilar to Stelara. 2 A pair of clinical trials ...

A new study highlights a significant medical concern for individuals suffering from psoriasis, revealing that even when skin ...

Residual inflammation persisted among patients with psoriasis despite optimal disease response to biologic therapies, putting ...

By Dennis Thompson HealthDay ReporterTHURSDAY, May 29, 2025 (HealthDay News) — Belly flab appears to be a stronger warning ...

Learn to distinguish between nail psoriasis and nail fungus through key visual differences, associated symptoms, and ...

May 27, 2025 — Researchers have found that central body fat, especially around the abdomen, is more strongly linked to psoriasis risk than total body fat, particularly in women. This link ...

In a country where chronic skin diseases affect millions, one institution is rewriting the rulebook. Kayakalp Global, based ...

Topical roflumilast 0.3% cream has been approved by the FDA to treat plaque psoriasis in patients 12 years and older since ...

The FDA approved a supplemental new drug application for roflumilast topical foam 0.3% for the treatment of plaque psoriasis ...